Company ProfilePremium

Nanyang New Development Limited (formerly Matex International Limited)

Company Profile Analysis

Ticker: M15.SI南洋新发展有限公司

ESOMAR 23 Corporate BadgeISO Certifications Badge
Nanyang New Development Limited - Company showcase

Year Founded & Workforce

1989

60 Employees

Nanyang New Development Limited logo

Nanyang New Development Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Nanyang New Development Limited Overview

Nanyang New Development Limited is a micro-cap specialty chemicals company listed on SGX Catalist. It was formerly Matex International, a dyestuff maker founded in 1989 and once one of Singapore's fastest-growing China-exposed industrial companies. Its core activity is still the formulation, sourcing and sale of textile dyestuffs and auxiliaries, led by the Megafix® reactive dye range. It also offers colour-measurement systems and some legacy distribution of third-party equipment. After it sold its Taixing manufacturing subsidiaries in 2022, the group became asset-light, with revenue of only S$5.9m in FY2025, about 73% of it from the PRC. A 2025 contest for control ended the founder's 36-year leadership and was followed by a trading suspension, a rebrand and a new PRC-oriented management team. The company now operates as a turnaround and "shell-plus" vehicle. It retains a small dye business, has net cash funded by a placement and convertible notes, and has a mandate to diversify into commodities trading and other new ventures. That diversification has not yet produced material revenue.


Company's own description (FY2025 Annual Report and results filings)

In its FY2025 Annual Report the company describes itself as an established manufacturer, supplier and marketer of quality dyestuffs and specialty chemicals, and of colour-measurement and computer-aided systems. It names its customer industries as textiles, paper, leather, detergents and polymers. It states a vision of becoming an integrated provider of "clean colour science technologies", with Singapore as a centre of excellence. It cites the Megafix® reactive dye series as its flagship. The condensed financial statements give the Company's principal activity as the formulation, manufacturing and sale of specialty chemicals, focused on dyestuff and auxiliaries for the textile industry (FY2025 results, 1 Mar 2026, Note 1). The group reports only geographical segments. Its stated reason is that business-segment reporting is not meaningful because revenue comes mainly from dyestuffs and auxiliaries (FY2025 results, Note 4).

Independent characterisation

The marketing language overstates the scale of the business today. The group is now a small, mostly trading-and-formulation dyestuff business with three features:

No owned dye synthesis capacity in China: since the 2022 sale of Matex Chemicals (Taixing) Co., Ltd (MCT) and Amly Chemicals Co., Ltd (ACL). PPE was only S$0.33m at 31 Dec 2025, after S$0.65m of impairments.

Small, shrinking revenue: Revenue fell from about S$20.9m in FY2021 (derived) to S$5.9m in FY2025, then rebounded to S$4.3m in 1H2026 on aggressive PRC pricing.

A heavy corporate cost base: relative to revenue. G&A was S$6.3m in FY2025, which is 108% of revenue. The FY2025 figure was inflated by S$0.876m of cessation payments and S$0.745m of legal and professional fees.

The 1H2026 results also suggest the PRC business has moved between legal entities. The 60%-owned Shanghai Matex Chemicals Co., Ltd (SMC) recorded only S$0.06m of revenue in 1H2026, against S$1.29m in 1H2025. Over the same period group PRC revenue rose to S$3.77m. Analyst inference: PRC sales now appear to run through wholly owned entities, most likely Matex Chemicals Technologies (Shanghai) and/or Shanghai JingCaiYuan. SMC is left as a loss-making shell with net liabilities of S$5.31m.

Business and revenue model

DimensionCharacterisationEvidence
Revenue type100% sale of goods recognised at a point in timeFY2025 results Note 4(a)
Product vs service mixAbout 100% products. Technical service is bundled; no separate service, subscription or licensing revenue is disclosed.FY2025 results
Value-chain positionMid-stream formulator and marketer. Buys dye intermediates and toll/third-party product ("low-cost sourcing") and sells to textile dye houses and mills.Placement use-of-proceeds categories ("Low Cost Sourcing"); 2022 sale of manufacturing plants
Customer typesTextile dyeing and finishing mills, garment and home-furnishing fabric processors, smaller exposure to paper, leather, detergent and polymer usersFY2025 AR corporate profile
End-marketsApparel and home textiles, mainly PRC; Singapore/Malaysia regional distribution; Indonesia targeted via the Johor relocation1H2026 commentary; Ipoh disposal announcement
New business mandatesCommodities trading (approved at EGM 13 Jan 2026); membrane materials (Shanghai JingCaiYuan, incorporated 16 Dec 2025); a gold bullion and jewellery venture (Gold Bar Pte Ltd, signed 6 Feb 2026, terminated 1 Apr 2026)FY2025 results Note 16; EGM minutes

Strategy

Stated strategy themes (FY2025 AR shareholder message, 1H2026 commentary, AGM minutes 30 Apr 2026)

  1. Stabilise the core. Cost discipline, more selective customer and product focus, and tighter credit and inventory control.

  2. Clean up the balance sheet. Impairments, rationalising non-core activities and stronger internal controls.

  3. Reposition beyond the legacy core. Pursue value-accretive new ventures or acquisitions with "strict focus" on capital efficiency.

  4. Expand overseas through partners. Distribution partnerships in Indonesia, Pakistan, Bangladesh and Sri Lanka.

  5. Innovate in products. R&D in differentiated dyes, integrated reactive, disperse and auxiliary portfolios, and digital textile printing inks. AGM discussion also mentioned products aimed at younger consumers.

  6. Restore trading. The Board told the 2026 AGM it believes SGX-ST requirements have been met and that it is awaiting guidance.

Initiatives in the last 24 months

InitiativeDateStatusQuantificationSource
Strategic placement to Nanyang CommercialNov 2024–Jan 2025CompletedS$4.158m gross; net S$3.941m allocated 30% market expansion, 20% low-cost sourcing, 30% new business, 20% working capitalCircular, 23 Dec 2024; 1H2026
Matex YG (Shanghai) associateJan 2024Operating, loss-making25% of RMB12m registered capital; 60% of capital to be paid by 31 Dec 2028; FY2025 revenue S$4k, loss S$367kNote 11
Diversification into commodities tradingApproved 13 Jan 2026Mandate only; one-off chromite ore back-to-back trade in FY2025No segment revenue yetEGM minutes; FY2025 results
Shanghai JingCaiYuan (membrane materials)Incorporated 16 Dec 2025Start-up—Note 10
Gold Bar Pte. Ltd. (bullion brokering and jewellery retail)Signed 6 Feb 2026Terminated 1–2 Apr 2026; disagreement over GBPL's proposed change of business directionIntended 55% stake (110,000 shares); about S$1m investmentSGX filings; The Edge
Convertible notes23 Jan 2026Funded 9 Mar 2026S$4.158m; 50% working capital, 50% new businessFY2025 AR; 1H2026
Sales force restructuring2025–2026OngoingHeadcount 65 to 60; personnel cost -31% in 1H20261H2026
Ipoh to Johor relocationJun–Sep 2026SPA signedRM1.9m disposal proceedsSGX filings
New Singapore laboratory2,026In progressEquipment prepayments (1H2026 prepayments S$0.178m)1H2026
Sustainability targetsFY2025 SRSetShort/medium/long-term intensity targets (see Section 20)FY2025 SR

Medium-term targets and guidance

No financial guidance or medium-term revenue or margin targets have been issued. The 1H2026 announcement states that no forecast or prospect statement had been disclosed.

Products & Services

Segment attribution is the analyst's, because the company reports no product segments. Pricing is not publicly disclosed for any product.

Certifications and credentials. 99 products certified to ZDHC Level 3 (MRSL). Collaboration with bluesign®, ETAD and Cradle to Cradle bodies. ISO 9001 and ISO 14001 systems. OH&S procedures aligned to OHSAS 18001. Holder of the LowCarbonSG logo (FY2025 Sustainability Report).

Product Portfolio

Product / brandCategoryDescription and capabilitiesTarget customerLaunch / latest yearSource

Megafix® reactive dye series

Dyestuffs (cellulosic)

Flagship reactive dyes for cotton and cellulosics; the company presents it as evidence of its in-house innovation

Cotton knit and woven dyehouses

Long-standing; year not publicly disclosed

FY2025 AR

Megafix® RE

Low-temperature reactive dyeing

Low-temperature exhaust dyeing that cuts energy use

Energy-cost-sensitive mills

—

FY2025 Sustainability Report; stocks.cafe

Megaperse CF

Disperse dye system

One-bath scouring, bleaching and dyeing; fewer process steps

Polyester/cotton blend processors

—

stocks.cafe profile

Megaperse SP

High-fastness disperse dyes

High-fastness dyes for polyester/spandex blends

Activewear and stretch-fabric dyers

—

stocks.cafe profile

Megapro® solutions

Auxiliaries / process chemicals

Efficiency auxiliaries that reduce energy use and replace conventional chemicals

Dyehouses

—

FY2025 Sustainability Report

Megapro ECO®

Salt-free dyeing auxiliary

Removes the need for salt in cotton reactive dyeing and lowers water and energy cost

Cotton dyers facing effluent limits

—

FY2025 Sustainability Report

Mebyo® Technology

Bio-based cleaning

Probiotic/prebiotic biodegradable cleaning alternative to conventional products

Institutional and industrial cleaning

—

FY2025 Sustainability Report

Optical brighteners

Specialty chemicals

Formulated and sold through Unimatex (Malaysia)

Textile, paper and detergent users

—

Note 10

Auxiliaries and textile chemicals

Specialty chemicals

Pre-treatment, dyeing and finishing auxiliaries

Mills

—

Corporate profile

Colour measurement and computer-aided systems

Equipment and systems

Supplied and serviced through MatexMega (65%); historically included distribution of X-Rite spectrophotometers

Mill QC laboratories

—

SGX corporate information; Note 10

Specialty process equipment and computerised control systems (third-party)

Distribution

Third-party equipment distribution

Mills

Legacy

SGX corporate information

Ultra-Fresh antimicrobial products (third-party)

Distribution

Antimicrobial textile finishes

Fabric finishers

Legacy

SGX corporate information

Garments and textile products trading

Trading

Import/export and wholesale through Dedot Trading (Shanghai)

Trade buyers

—

Note 10

Membrane materials

New business

Sale of new membrane materials through Shanghai JingCaiYuan

—

Entity formed Dec 2025

Note 10

Commodities trading

New business (mandate)

Shareholder-approved diversification. FY2025 included a one-off back-to-back chromite ore trade, booked as other income.

—

Mandate Jan 2026

FY2025 results; EGM minutes

Digital textile printing inks

Development focus

Management names the shift to digital printing inks as a growth area. No product launch disclosed.

Digital printers

Planned

1H2026 commentary

“—” = not publicly disclosed.

Financial Narrative

Income statement

The FY2022 EPS of 2.33 cents is the fully diluted figure reported by The Edge. FY2022 other income of about S$12.5m was mainly gains on disposal of MCT and ACL (The Edge's article prints "US$12.5 million", which appears to be a typo for S$). FY2021–FY2022 "net income" is the "earnings" figure The Edge reported; whether it is attributable or total is not specified.

Margins and growth

Revenue CAGR. FY2021–FY2025: about -27.2% a year (using derived FY2021). FY2023–FY2025 (post-disposal basis): -10.7% a year.

Commentary: revenue. There are two distinct phases. FY2021–FY2023 is structural shrinkage, driven by the 2022 sale of the Taixing plants (MCT and ACL), COVID-era weakness in PRC textiles and Sri Lanka's 2022 crisis. FY2023–FY2025 is cyclical and competitive erosion. Management attributes the FY2025 decline of 16.3% to weak global consumption, US/EU slowdown, low-cost import competition and overcapacity (FY2025 results, para 8).

Commentary: gross margin. Gross margin peaked at about 21–22% in FY2023–FY2024, when the asset-light sourcing model worked. It compressed to 14.8% in FY2025, and to 9.3% in 2H2025, because of price competition and S$0.313m of inventory write-downs at the China subsidiary. In 1H2026 it recovered to 17.6%, but management says this came from deliberate price cuts to regain share. That points to volume-led rather than margin-led recovery.

Commentary: cost base and FY2025 losses. G&A rose 56% to S$6.34m in FY2025. The FY2025 loss before tax of S$7.74m includes these non-recurring items:

Even after adding back about S$3.9m, the underlying loss is about S$3.8m. That is consistent with FY2023 and FY2024 and shows a structural loss of roughly S$3.3–4.0m a year before the 2026 restructuring.

Balance sheet

FY2021–FY2022 total assets, liabilities, equity and cash are from TipRanks (secondary).

Commentary. Equity attributable to owners fell by more than half in two years, from S$12.7m (FY2023) to S$6.1m (FY2025), despite the S$4.158m placement in January 2025. Losses have absorbed more than the new capital. The cash balance is the group's main asset, at about 71% of total assets in FY2025. Non-controlling interests have been increasingly negative because 60%-owned SMC has net liabilities of S$5.09m. Some intra-group liabilities sit in SMC (SMC current liabilities S$6.86m against current assets S$1.76m), which creates possible ring-fencing questions for PRC creditors.

Interim position, 30 June 2026 (1H2026 results, 11 Aug 2026)

Commentary. Revenue rose 70% in 1H2026 and the loss nearly halved, helped by personnel costs down to S$0.881m from S$1.282m and FX losses down to S$1k from S$397k. On a TTM basis (FY2025 less 1H2025 plus 1H2026), revenue is about S$7.63m and the net loss about S$6.73m. The cash rise to S$9.45m was funded by debt (convertible notes), not by operations. On an adjusted basis, net cash after the notes and loans is about S$3.8m.

Cash flow

FY2021–FY2023 capex is derived as OCF minus FCF from TipRanks. FY2024 investing outflows included S$1.3m for an "other long-term investment" (unquoted equity, later written down to nil through OCI), S$0.225m for the associate and a S$1.138m refund to a former subsidiary.

Commentary. Operating cash burn has accelerated: -S$0.46m (FY2023), -S$2.40m (FY2024), -S$5.19m (FY2025), then -S$2.47m in 1H2026. The S$15.7m of disposal proceeds received in 2022–2023 has been largely consumed by losses, investments and debt repayment. External capital raised since January 2025 totals S$8.3m (placement plus convertible notes). Of the placement, S$2.36m was unutilised at 11 Aug 2026, and none of the S$4.105m net note proceeds had been used.

Key ratios

ROIC and net debt/EBITDA are not meaningful: invested capital is negative because of net cash, and EBITDA is negative. Ratios are analyst calculations from filed figures.

Inflections. (1) The 2022 disposals turned the group into a cash-rich, asset-light vehicle. (2) The 2025 control contest added at least S$1.6m of one-off costs. (3) 1H2026 shows the first sign of operating stabilisation (revenue up, G&A down 35%), but gross margin is being sacrificed and the convertible notes add interest cost (finance expenses of S$0.112m in 1H2026, against S$0.027m in 1H2025).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityPrincipal activityCountryGroup interest (%)

Nanyang New Development Limited

Holding; dyestuff formulation and sale

Singapore

Parent

Matex Holdings Pte Ltd

General wholesale trading and dyestuffs manufacturing

Singapore

100

Shanghai Matex Chemicals Co., Ltd (SMC)

Sale of dyestuffs

PRC

60

Unimatex Sdn Bhd (USB)

Formulation, manufacture and sale of dyestuffs, auxiliaries and optical brighteners

Malaysia

100

Matex Chemicals Technologies (Shanghai) Co., Ltd (MTL)

General wholesale trading

PRC

100

Dedot Trading (Shanghai) Co., Ltd

Import/export and wholesale of garments, textiles and chemicals

PRC

100 (via MHPL)

MatexMega Pte. Ltd.

Manufacture and repair of measuring devices and process-control equipment

Singapore

65 (via MHPL)

Matex Holdings (HK) Limited

General wholesale trade

Hong Kong

100 (via MHPL)

Shanghai JingCaiYuan New Materials Co., Ltd (incorporated 16 Dec 2025)

Sale of new membrane materials; technology and agency import/export

PRC

100 (via MTL)

Matex YG (Shanghai) Material Tech Ltd (associate)

Materials technology

PRC

25 (via MTL)

Revenue by Segment

Segment metric (SGD Mn)FY2023FY2024FY2025

PRC external revenue (SGD Mn)

—4.7854.304

Other Asia Pacific external revenue (SGD Mn)

—2.2171.555

PRC inter-segment revenue (SGD Mn)

—3.0682.078

PRC segment result (SGD Mn)

—-1.278-3.087

Other Asia Pacific segment result (SGD Mn)

—-2.239-8.840

Eliminations, segment result (SGD Mn)

—0.0074.168

Group revenue (SGD Mn)

7.3547.0025.859

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Segment ratios

Segment ratiosFY2024FY2025

PRC share of group revenue (%)

68.373.5

Other Asia Pacific share of group revenue (%)

31.726.5

PRC external revenue growth YoY (%)

—-10.1

Other Asia Pacific external revenue growth YoY (%)

—-29.9

PRC segment margin (result / external revenue, %)

-26.7-71.7

Revenue by Segment (1H2025–1H2026)

Segment metric (SGD Mn)1H20251H2026

PRC external revenue (SGD Mn)

1.8484.085

Other Asia Pacific external revenue (SGD Mn)

0.9340.518

Eliminations (SGD Mn)

-0.267-0.319

PRC segment result (SGD Mn)

-0.573-0.325

Other Asia Pacific segment result (SGD Mn)

-1.735-0.874

Income Statement and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (SGD Mn)

20.914.67.3547.0025.859

Gross profit (SGD Mn)

2.632.51.6081.4650.865

Other income (SGD Mn)

0.33412.50.0480.1910.332

Operating income, EBIT excl. associate and net finance (SGD Mn)

———-3.450-7.668

EBITDA, EBIT + D&A (SGD Mn)

———-2.775-7.444

Pre-tax income (SGD Mn)

——-4.025-3.276-7.741

Net income, total (SGD Mn)

-4.97.3-4.041-3.289-7.746

Net income attributable to owners (SGD Mn)

——-3.310-2.654-6.771

EPS basic (SGD cents)

—2.33-0.98-0.73-1.34

EPS diluted (SGD cents)

—2.33-0.98-0.73-1.34

Dividends per share (SGD cents)

———00

Weighted avg shares (M)

——337.3361.7503.9

Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Gross margin (%)

12.617.221.920.914.8

Operating (EBIT) margin (%)

———-49.3-130.9

EBITDA margin (%)

———-39.6-127.1

Net margin, total (%)

-23.450.0-54.9-47.0-132.2

Revenue growth YoY (%)

—-30.3-49.6-4.8-16.3

FY2025 non-recurring / non-cash item

FY2025 non-recurring / non-cash itemSGD Mn

Cessation payments (Dr Tan Pang Kee, Mr Tan Guan Liang, Ms Lok Fong Meng)

0.876

Legal and professional fees (settlement and corporate exercises)

0.745

Impairment of financial assets (incl. S$0.95m irrecoverable bills/other receivable)

1.061

Impairment of non-financial assets (PPE)

0.651

Inventory write-down

0.313

FX loss (MYR Bn weakness)

0.256

Total identified

3.902

Balance Sheet and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Total assets (SGD Mn)

30.2224.2521.39815.24411.848

Cash and equivalents incl. fixed deposits (SGD Mn)

6.4611.9216.378.8568.355

Total liabilities (SGD Mn)

23.149.159.1527.2857.815

Total equity (SGD Mn)

7.0815.1012.2467.9594.033

Equity attributable to owners (SGD Mn)

——12.7019.0496.053

Non-controlling interests (SGD Mn)

——-0.455-1.090-2.020

Short-term debt: term loans + current leases (SGD Mn)

———1.2651.847

Long-term debt: non-current leases (SGD Mn)

———0.2260.022

Total debt (SGD Mn)

———1.4911.869

Net debt, negative = net cash (SGD Mn)

———-7.365-6.486

Goodwill and intangibles (SGD Mn)

———00.008

Working capital (SGD Mn)

——11.0906.1743.714

NAV per share (SGD cents)

——3.512.501.17

Cash Flow and Margin Analysis (%)

Metric1H20251H2026

Revenue (SGD Mn)

2.5154.284

Gross profit (SGD Mn)

0.5550.755

Gross margin (%)

22.117.6

G&A expenses (SGD Mn)

2.4821.622

Loss before tax (SGD Mn)

-2.313-1.311

Net loss, total (SGD Mn)

-2.318-1.306

Net loss attributable (SGD Mn)

-2.085-1.292

EPS basic (SGD cents)

-0.49-0.25

Operating cash flow (SGD Mn)

-3.455-2.472

Cash at period end (SGD Mn)

10.0509.447

Balance Sheet and Per-Share Data (31-Dec-2025–30-Jun-2026)

Balance sheet item (SGD Mn)31-Dec-202530-Jun-2026

Cash (SGD Mn)

8.3559.447

Term loans (SGD Mn)

1.8321.230

Convertible notes (SGD Mn)

04.158

Lease liabilities (SGD Mn)

0.0370.293

Total equity (SGD Mn)

4.0332.742

Equity attributable (SGD Mn)

6.0534.853

NAV per share (SGD cents)

1.170.94

Working capital (SGD Mn)

3.7146.428

Cash Flow

MetricFY2021FY2022FY2023FY2024FY2025

Operating cash flow (SGD Mn)

0.238-1.17-0.456-2.403-5.194

Capex: PPE purchases (SGD Mn)

0.2730.080.2980.5660.085

Free cash flow (SGD Mn)

-0.035-1.25-0.754-2.969-5.279

Investing cash flow (SGD Mn)

-0.26711.773.82-3.2240.171

Financing cash flow (SGD Mn)

1.91-4.821.12-1.8764.719

Equity issued (SGD Mn)

———04.158

Dividends paid (SGD Mn)

———00

Share buybacks (SGD Mn)

———00

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2023FY2024FY2025

ROE, attributable loss / ending attributable equity (%)

-26.1-29.3-111.9

ROA, total loss / ending total assets (%)

-18.9-21.6-65.4

Current ratio (x)

2.291.891.48

Debt / equity (x)

—0.190.46

Interest coverage, EBIT / interest expense (x)

—-67.6-108.0

Asset turnover, revenue / average assets (x)

0.320.380.43

Days sales outstanding, trade + notes (days)

—9567

Days inventory outstanding (days)

—10286

Days payables outstanding (days)

—8473

Cash conversion cycle (days)

—11380

Revenue by Region

RegionFY2023FY2024FY2025

PRC revenue (SGD Mn)

—4.7854.304

Singapore revenue (SGD Mn)

—1.5601.044

Malaysia revenue (SGD Mn)

—0.6570.511

Total revenue (SGD Mn)

7.3547.0025.859

Growth and mix (%)

Growth and mix (%)FY2024FY2025

PRC growth YoY (%)

—-10.1

Singapore growth YoY (%)

—-33.1

Malaysia growth YoY (%)

—-22.2

PRC share (%)

68.373.5

Singapore share (%)

22.317.8

Malaysia share (%)

9.48.7

Revenue by Region (1H2025–1H2026)

Region1H20251H2026

PRC revenue (SGD Mn)

1.5813.766

Singapore revenue (SGD Mn)

0.6620.369

Malaysia revenue (SGD Mn)

0.2720.149

Share Price & Returns

Reference pointDatePrice (SGD)Source

Trading level

4 May 2020

0.019

The Edge Singapore

Close

28 Feb 2023

0.025

The Edge Singapore

VWAP

30 Oct 2024

0.018

MT Newswires

Placement price

24 Jan 2025

0.027

Subscription announcement

Last traded before suspension

Jul 2025

0.022

The Edge Singapore (Apr 2026)

Convertible note conversion price

Jan 2026

0.0198

1H2026 results

Valuation Snapshot

MultipleValueBasis

Market cap (SGD Mn)

11.35

515.7m shares × S$0.022

P/B (x)

2.34

Attributable equity S$4.853m (30 Jun 2026)

Price / NAV per share (x)

2.34

NAV 0.94 cents

EV (SGD Mn)

7.58

Market cap + debt S$5.68m (loans, leases, notes) - cash S$9.45m; excludes negative NCI

EV / Sales TTM (x)

0.99

TTM revenue about S$7.63m

Capital Markets

ItemDetail

Analyst consensus

None; no sell-side coverage identified

Dividend history and policy

No dividends for FY2024, FY2025 or 1H2026; the Board cites the operational loss position. No formal policy disclosed.

Buyback authorisation

None disclosed

Credit ratings (Moody's / S&P / Fitch)

Not rated

Capital raised since 2023

S$1.25m (CSF, 2023); S$4.158m placement (Jan 2025); S$4.158m convertible notes (Mar 2026)

Capital Instruments

InstrumentAmount (SGD Mn)MaturitySecurity

PRC bank term loan

1.230

Within 12 months; rollover at bank's discretion

Corporate guarantee plus directors' joint and several guarantees

Unsecured convertible notes

4.158

Aug 2027

Unsecured; convertible at S$0.0198

Lease liabilities

0.293

2026–2028

Hire purchase (S$6k) secured on asset

Analyst Conclusions

Management guidance

There is no quantitative guidance. Management expects a challenging near-term environment. It intends to stabilise the core business, expand overseas through partners, benefit from expected normalisation of PRC dye prices, and pursue value-accretive new ventures (FY2025 AR outlook; 1H2026 para 10).

Consensus

No sell-side consensus exists.

Bull case

  1. The turnaround is visible. 1H2026 revenue rose 70% and the loss before tax narrowed 43%. If 2H2026 matches 1H2026, FY2026 revenue would be about S$8.5m and the loss would roughly halve from FY2025.

  2. Cash supports the valuation. Cash of S$9.45m is close to the S$11.35m market cap. EV is only about S$7.6m, roughly 1x TTM sales.

  3. Resumption is a catalyst. A newly constituted board, a sponsor in place, and statements that SGX requirements have been met could bring an SGX no-objection, with re-rating potential.

Bear case

  1. Structural losses. Even excluding about S$3.9m of FY2025 one-offs, the core lost about S$3.8m. The 1H2026 recovery was bought through lower margins, with gross margin down 4.5 percentage points.

  2. Dilution and control risk. Conversion at S$0.0198, below the last trade, would issue 210m shares and could hand effective influence to the noteholders.

  3. Delisting and liquidity risk. The suspension has passed 14 months. If the notes are not converted, S$4.16m is repayable in Aug 2027, against annual cash burn of S$5m in FY2025.

Key catalysts and monitorables (next 12 months)

Catalyst / monitorableExpected timingWhy it matters
SGX RegCo decision on resumption of tradingUnknownLiquidity, valuation, delisting risk
FY2026 results (2H2026 trends)By end Feb 2027Tests whether the turnaround is sustainable
Deployment of S$3.2m new-business fundsRollingQuality of capital allocation
Convertible note conversion decisionsBefore Aug 2027Dilution and control
Completion of Ipoh disposal and Johor relocation2H2026Cost and logistics
Singapore HQ and lab relocationFrom Sep 2026Operational continuity
Shareholding changes (Nanyang Commercial, Khua bloc, noteholders)RollingControl dynamics
Statistics of shareholdings / free float in FY2026 ARApr 2027Catalist free-float compliance
Gross margin trajectory in the PRC2H2026Pricing discipline

Analyst verdict

Nanyang New Development is best understood as a restructured shell built around a residual dyestuff franchise. It is not an operating specialty-chemicals company in the usual sense. The former Matex International sold its manufacturing heart in 2022 and then lost most of the disposal cash to recurring losses, investments that later had to be written off, and a costly 2025 boardroom battle. That battle ended the founding family's 36-year leadership and led to a suspension that has lasted more than fourteen months. The new board, aligned with Nanyang Commercial and chaired by an experienced independent former SGX regulator, has done the necessary clean-up work. It has impaired doubtful assets, settled with former management, cut personnel costs, secured S$4.16m of note funding and delivered a credible first-half rebound in PRC sales.

The economics remain fragile. FY2025 revenue of S$5.9m cannot support a listed-company cost base. Expensed R&D is effectively nil. The 1H2026 recovery was achieved by sacrificing margin in an overcapacity market where scale producers set prices. The diversification mandate has so far produced one aborted bullion venture and a one-off ore trade. The convertible notes, priced below the last traded share price, put a large share of future value in noteholders' hands and leave open the question of who will control the company.

On the last traded price, the equity is valued at about 2.3x book and about 1x TTM sales, with net cash providing some downside cushion. Investors are mainly buying an option on resumption of trading and a successful pivot, not the earnings of a proven business. We regard the risk/reward as speculative and event-driven. Monitor four things: an SGX no-objection, sustained 2H2026 gross margins above about 18%, disciplined deployment of new-business funds, and transparent disclosure of shareholdings and conversions. Without progress on resumption and recurring profitability by FY2026, delisting and further dilution are realistic outcomes.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameTitleAppointedBackgroundEducation

Mr James Kho Chung Wah

Non-Executive Chairman and Independent Director; AC Chairman

ID from 15 May 2025; Chairman from 26 Nov 2025

CEO and co-founder of Willan Capital Pte. Ltd.; senior roles at multinational and investment banks; began career in SGX Issuer Regulation; ID of Rich Capital Holdings and OceanScape International

B.Bus (Hons), NTU; CFA

Dr Liu Shen

Executive Director and Chief Technical Officer

17 Oct 2025

20+ years in applied and fine chemicals in the PRC: GM Fuzhou Xingchen Pharmaceutical (2021–22); GM Hengshui Quark Biotechnology (2023–24); adviser at Hunan Ruiguan Biotechnology (2024–25); DGM, Hunan Jingfeng Chemical Technology (2025). Executive Manager of Amly Chemicals (2014–21) and General Affairs Manager at SMC (2012–14). Nominated in Nanyang Commercial's July 2025 requisition.

PhD Applied Chemistry, Dalian University of Technology; MSc, Qiqihar University

Dr Fu ShaoHai

Independent Director; RC Chairman

5 Feb 2026

Dean, College of Textile Science & Engineering, Jiangnan University (2017–Nov 2025); now Director of Development Planning at Jiangnan University

PhD Textile Science & Engineering, Jiangnan; MSc and BSc, Qingdao University

Ms Sim Kai Li

Independent Director

Appointment announced 24 Jul 2026

——

Executive Leadership Team

NameTitleSinceBackground

Mr Chen HongBo

Chief Executive Officer

—

Independent investor since 2018 in healthcare, gaming/eSports, automotive aftermarket, government data services and community sports; prior senior management roles

Mr Seow Han Khye

CFO and Joint Company Secretary (co-sec from 5 Feb 2026)

CFO since at least 2023

Former CFO of Luma Group; FCCA

Ms Shirley Tan Sey Liy

Joint Company Secretary

Reappointed

FCS, FCG

Board & Management Changes

DateChangeContext

5 Apr 2024

Dr John Chen Seow Phun retires as Chairman

Long-serving chairman

1 May 2024

Mr Chiang Yao Chong appointed ID and AC Chair

Board refresh

1 Aug 2024

Mr Wang Daofu re-designated Non-Executive Chairman

Succession

28 Apr 2025

Foo Der Rong retires; Chiang Yao Chong not re-elected at AGM

First visible shareholder dissent after Nanyang Commercial's entry

1/15 May 2025

Chng Hee Kok and James Kho appointed IDs

Rebuild of independent bench

7 Jul 2025

Nanyang Commercial requisitions removal of Dr Tan and Mr Tan; nominates Liu Shen and Kok Jun Yan as EDs

Control contest

16 Sep 2025

Dr Tan Pang Kee, Mr Tan Guan Liang and Mr Wang Daofu resign; Tan Chong Huat appointed Chairman; Dr Danny Oh appointed ED

Settlement plus minority-requisitioned EGM

30 Sep 2025

Tan Chong Huat re-designated independent

Catalist compliance

17 Oct 2025

Dr Liu Shen appointed ED

Nanyang Commercial-aligned management

By 5 Nov 2025

Mr Chen Hongbo appointed CEO

New management

5 Nov 2025

Tan Chong Huat resigns, citing personal commitments and stabilised operations

Interim chair exits

26 Nov 2025

James Kho becomes Chairman

—

5 Feb 2026

Dr Fu ShaoHai appointed ID

Textile-science expertise

30 Apr 2026

Chng Hee Kok retires

—

24 Jul 2026

Ms Sim Kai Li appointed ID

—

Major Shareholders

HolderSharesStake (%)Basis / dateSource

Nanyang Commercial Management Pte. Ltd. (sole shareholder and director: Mr Wang Weidong)

154,000,00029.86

Since 24 Jan 2025

Requisition notice, 7 Jul 2025

Dr Tan Pang Kee (founder)

—

21.82 in 2020, before dilution

Current holding not publicly verified

The Edge (2020)

Mr Khua Kian Keong (direct and via CSF Fund I / DBS Nominees)

—

14.96 in 2020, before dilution

Directed the "New Requisitionists" in Aug–Sep 2025

The Edge (2020); TipRanks

CSF Fund I Pte. Ltd.

—

Became substantial shareholder after the 2023 placement

2023

Matex announcement, 5 Jun 2023

Convertible note holders: Ascentas Capital Management Limited and Li Baohua

210,000,000 potential

28.9 of enlarged capital if fully converted

Notes due Aug 2027

1H2026 results

Competitive Landscape

Key Competitors

#CompetitorListingSegment overlapRelative scale vs NNDLPositioning vs NNDL
1

Zhejiang Longsheng Group (owner of DyStar)

SSE: 600352

Disperse and reactive dyes, auxiliaries

Several orders of magnitude larger

Global leader; integrated intermediates

2

DyStar

Subsidiary of Longsheng

Reactive/disperse dyes, auxiliaries, colour services

Multinational

Premium brand-compliant supplier

3

Zhejiang Runtu Co., Ltd

SZSE: 002440

Disperse and reactive dyes

Several orders of magnitude larger

Low-cost PRC scale producer

4

Zhejiang Jihua Group

SSE: 603980

Dyes and intermediates

Much larger

PRC integrated producer

5

Jiangsu Yabang Dyestuff

SSE: 603188

Disperse dyes

Much larger

PRC producer

6

Archroma (incl. ex-Huntsman Textile Effects)

Private (SK Capital)

Dyes, auxiliaries, sustainable solutions

Multinational

Sustainability-led premium

7

Atul Ltd

NSE: ATUL

Reactive and other dyes

Much larger

Indian integrated chemicals

8

Kiri Industries

NSE: KIRIINDUS

Reactive dyes, intermediates

Much larger

Indian reactive-dye specialist

9

Bodal Chemicals

NSE: BODALCHEM

Reactive dyes, intermediates

Much larger

Integrated Indian producer

10

Everlight Chemical Industrial

TWSE: 1711

Disperse and reactive dyes

Much larger

Taiwanese specialty dyes

11

CHT Group

Private (Germany)

Auxiliaries, dyes

Multinational

Auxiliary specialist

Competitor Detail

MetricNNDL FY2025

Revenue (SGD Mn)

5.859

Revenue growth (%)

-16.3

Gross margin (%)

14.8

Net margin (%)

-132.2

R&D / revenue (%)

0.03

Company Snapshot

$4.5M

Revenue

60

Employees

1989

Founded

Bukit Merah Central, Singapore

Headquarters

SWOT Analysis

Strengths

  • Net cash. Cash of S$9.45m at 30 Jun 2026 against S$1.23m of bank loans and S$4.16m of convertible notes, giving adjusted net cash of about S$3.8m (1H2026 results).
  • Certified eco-portfolio. 99 products at ZDHC Level 3; ISO 9001 and ISO 14001; LowCarbonSG logo (FY2025 SR).
  • Recognised brands. Megafix® reactive dyes and Megapro ECO® salt-free technology (FY2025 AR).
  • Early operating recovery. 1H2026 revenue +70% to S$4.28m; G&A -35% to S$1.62m; loss before tax -43% (1H2026 results).
  • Technical leadership added. CTO Dr Liu Shen (PhD, 20+ years in fine chemicals, former Amly executive manager) and ID Dr Fu ShaoHai (former Jiangnan University textile dean) (FY2025 AR).
  • Asset-light structure. PPE only S$0.39m, with no heavy plant maintenance capex (FY2025 capex S$0.085m).

Weaknesses

  • Persistent losses. Losses after tax of S$4.0m (FY2023), S$3.3m (FY2024) and S$7.7m (FY2025) (FY2025 AR financial highlights).
  • Sub-scale revenue. S$5.86m in FY2025, down about 72% from about S$20.9m (derived) in FY2021.
  • Negligible R&D. S$2k a year in FY2024 and FY2025 (FY2025 results Note 5).
  • Cost base far above gross profit. FY2025 G&A of S$6.34m against gross profit of S$0.87m.
  • Loss-making 60% PRC subsidiary. SMC has net liabilities of S$5.31m (30 Jun 2026) and revenue of S$0.06m in 1H2026.
  • Governance instability and template disclosure. Thirteen board changes in 15 months. The FY2025 Sustainability Report contains apparently template language referring to the "medical aesthetic sector", "patients" and "quality of care", which do not apply to a dye company. This raises questions about the quality of review.

Opportunities

  • Resumption of trading could re-rate the stock and restore access to capital. The Board said at the 2026 AGM that it believes SGX requirements are met.
  • Overseas partner channels in Indonesia, Pakistan, Bangladesh and Sri Lanka (1H2026 commentary).
  • Normalising PRC dye prices after a long price war (1H2026 commentary, citing SunSirs).
  • Digital printing inks and integrated reactive/disperse/auxiliary portfolios, flagged by management as new competitive models.
  • Unused growth capital. S$1.18m (placement) plus S$2.05m (notes) earmarked for new business (1H2026 use of proceeds).
  • Johor relocation to cut logistics cost and serve Singapore and Indonesia; Ipoh disposal proceeds of RM1.9m.

Threats

  • Delisting risk. Suspended since 23 Jul 2025. The 12-month mark passed on 23 Jul 2026, and resumption depends on SGX RegCo.
  • Dilution and control shift. Full note conversion adds 210m shares, 40.72% of existing capital (1H2026).
  • Cash burn. Operating outflow of S$5.19m in FY2025 and S$2.47m in 1H2026, against cash of S$9.45m. The notes are repayable in Aug 2027 if not converted.
  • Low-cost competition. Singapore and Malaysia revenue down 44–45% in 1H2026.
  • FX. RMB/SGD swings (FY2025 FX loss S$0.26m; 1H2025 S$0.40m).
  • Execution risk in diversification. The Gold Bar venture was terminated within two months; commodities trading has produced no recurring revenue yet.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
28 Apr 202535th AGM: Tan Pang Kee and Tan Guan Liang re-elected; ID Chiang Yao Chong not re-elected; Foo Der Rong retiresEarly sign of shareholder realignment after the placement
1/15 May 2025Chng Hee Kok and James Kho appointed IDsBoard rebuilt
15 May 2025AGM minutes releasedGovernance record
7 Jul 2025Nanyang Commercial (29.86%) requisitions EGM to remove founder and son and appoint Liu Shen and Kok Jun YanControl contest begins
15 Jul 2025RHT Capital's sponsorship endsCatalist issuer without a sponsor
16–22 Jul 2025Trading halt, extended because the incoming sponsor needed more review timeLiquidity frozen
23 Jul 2025Trading suspension requested to onboard a sponsor and ensure full disclosureSuspension continues as of last check
Late Jul–Aug 2025Nanyang Commercial issues notice for an EGM on 21 Aug, moved to 28 Aug. Board says the notice is defective under the constitution.Procedural dispute
Aug 2025Second requisition from CSF Fund I and DBS Nominees (instructed by Khua Kian Keong), the "New Requisitionists"Competing minority bloc
15 Aug 2025Notice of EGM (Nanyang Commercial) for 11 Sep 2025–
22 Aug 2025Notice of EGM (New Requisitionists) for 16 Sep 2025: remove both Tans, appoint Tan Chong Huat–
1–3 Sep 2025SGX RegCo queries on EGMs, legal proceedings and disclosure; company respondsRegulatory scrutiny
5 Sep 2025Interim injunction (Justice Hoo Sheau Peng) in HC/OA 790/2025 restrains Nanyang Commercial's EGM; Dr Tan and Mr Tan are claimantsCourt intervention
12 Sep 2025Clarification of response to SGX queries (register-of-members requests)Disclosure correction
14–15 Sep 2025Settlement agreement with Dr Tan and Mr Tan, including one year's remuneration as cessation paymentFounder exit negotiated
16 Sep 2025Founder, son and chairman Wang Daofu resign; Tan Chong Huat appointed Chairman, Dr Danny Oh EDBoard overturned
22 Sep 2025Subscription agreements with Lim Yan Peng and Gan Peiling terminatedRemoves contested dilution
26 Sep 2025OA 733 and OA 790 discontinued. The court indicated it would have enjoined the subscription agreements if OA 733 had not been discontinued.Litigation ends
30 Sep 20251H2025 results: revenue S$2.5m (-27%), net loss S$2.3mLate interim results
Early Oct 2025Responses to SGX queries on the settlement, board changes and business plansRegulatory scrutiny
17 Oct 2025Dr Liu Shen appointed EDControlling shareholder's nominee installed
Late Oct–early Nov 2025Chen Hongbo appointed CEONew management
4 Nov 2025Update: EGM planned for Jan 2026 covering cessation payments; notice by 19 Dec 2025–
5 Nov 2025Tan Chong Huat resigns as Chairman and ID–
26 Nov 2025James Kho appointed Chairman–
16 Dec 2025Shanghai JingCaiYuan New Materials incorporatedNew business
13 Jan 2026EGM approves diversification, name change and new constitutionStrategic reset
15 Jan 2026Cessation payments settled (S$462k and S$109k cash plus vehicle)Cash outflow
19 Jan 2026SMC legal representative changed from Dr Tan to Dr LiuPRC control secured
23 Jan 2026S$4.158m convertible note subscription agreementFunding
26–28 Jan 2026Change of name to Nanyang New Development LimitedRebrand
2 Feb 2026Counter renamed "Nanyang NewDev"–
4–5 Feb 2026Dr Fu ShaoHai appointed ID; Seow Han Khye appointed joint company secretary–
6–7 Feb 202655% subscription in Gold Bar Pte. Ltd. announcedDiversification attempt
13–23 Feb 2026Application for extension of time under Catalist Rule 705(1), later returnedReporting timeliness
1 Mar 2026FY2025 results: revenue S$5.9m, net loss S$7.7mLoss widens
9 Mar 2026Full convertible note proceeds receivedLiquidity
1–2 Apr 2026Gold Bar agreement terminatedDiversification setback
14 Apr 2026FY2025 Annual Report and Sustainability Report; Chng Hee Kok retirement announced–
30 Apr 202636th AGM; trading still suspended pending SGX-ST guidance–
28 May 2026AGM minutes published–
30 Jun 2026Proposed disposal of Ipoh property for RM1.9mAsset monetisation
24 Jul 2026Ms Sim Kai Li appointed ID–
11 Aug 20261H2026 results: revenue +70%, net loss S$1.3mFirst signs of stabilisation
16 Aug 2026Replacement (amended) half-year results filedCorrection filing
31 Aug 2026Singapore office and lab lease expiry; relocation plannedOperational
10 Sep 2026Update on Ipoh disposal: SPA signedMost recent filing found

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Revenue by Segment (FY2023–FY2025): PRC external revenue fell from SGD 4.8 Mn in FY2024 to SGD 4.3 Mn in FY2025.
Nanyang New Development Limited — Revenue by Segment (FY2023–FY2025)
Series (SGD Mn)FY2023FY2024FY2025
PRC external revenue—4.84.3
Other Asia Pacific external revenue—2.21.6
PRC inter-segment revenue—3.12.1
PRC segment result—-1.3-3.1
Other Asia Pacific segment result—-2.2-8.8
Eliminations, segment result—04.2
Group revenue7.475.9

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. [SGX — Matex corporate information (Nanyang New Development)]( (links.sgx.com)
  2. [FinancialFilings — Nanyang New Development company page and filings index]( (financialfilings.com)
  3. [FinancialFilings — FY2025 full-year results (1 Mar 2026)]( (financialfilings.com)
  4. [FinancialFilings — 1H2026 results (11 Aug 2026)]( (financialfilings.com)
  5. [FinancialFilings — FY2025 Annual Report (14 Apr 2026)]( (financialfilings.com)
  6. [FinancialFilings — 2026 filings archive]( (financialfilings.com)
  7. [SGX — FY2025 results announcement (NYND)]( (links.sgx.com)
  8. [SGX — Receipt of requisition notice (7 Jul 2025)]( (links.sgx.com)
  9. [SGX — Request for suspension (23 Jul 2025)]( (links.sgx.com)
  10. [SGX — Trading halt extension (21 Jul 2025)]( (links.sgx.com)
  11. [SGX — Notice of EGM 11 Sep 2025]( (links.sgx.com)
  12. [SGX — Notice of EGM 16 Sep 2025]( (links.sgx.com)
  13. [SGX — Clarification on response to SGX queries (12 Sep 2025)]( (links.sgx.com)
  14. [SGX — Resignation of Tan Chong Huat (6 Nov 2025)]( (links.sgx.com)
  15. [SGX — Board changes (14 May 2025)]( (links.sgx.com)
  16. [SGX — EGM results 15 Jan 2025 (subscription)]( (links.sgx.com)
  17. [SGX — Circular for share subscription (23 Dec 2024)]( (links.sgx.com)
  18. [SGX — Subscription announcement (3 Nov 2024)]( (links.sgx.com)
  19. [SGX — ACL disposal update]( (links.sgx.com)
  20. [SGX — MCT disposal update]( (links.sgx.com)
  21. [SGX — MCT disposal update 2023]( (links.sgx.com)
  22. [SGX — Proposed diversification (13 Dec 2021)]( (links.sgx.com)
  23. [SGX — CSF Fund I placement (5 Jun 2023)]( (links.sgx.com)
  24. [The Edge Singapore — FY2022 results]( (testing.dev.theedgesingapore.com)
  25. [The Edge Singapore — Dye maker Matex feature]( (testing.dev.theedgesingapore.com)
  26. [The Edge Singapore — Gold Bar investment aborted]( (testing.dev.theedgesingapore.com)
  27. [The Edge Singapore — Eric Khua stake in Matex (2020)]( (testing.dev.theedgesingapore.com)
  28. [minichart — SGX query response on settlement (Oct 2025)]( (minichart.com.sg)
  29. [minichart — EGM Jan 2026 resolutions]( (minichart.com.sg)
  30. [minichart — AGM 2026 minutes]( (minichart.com.sg)
  31. [minichart — Ipoh property disposal]( (minichart.com.sg)
  32. [minichart — Gold Bar termination]( (minichart.com.sg)
  33. [minichart — 1H2025 results]( (minichart.com.sg)
  34. [TipRanks — balance sheet history]( (tipranks.com)
  35. [TipRanks — cash flow history]( (tipranks.com)
  36. [TipRanks — board restructuring (Sep 2025)]( (tipranks.com)
  37. [TipRanks — requisition by CSF Fund I / DBS Nominees]( (tipranks.com)
  38. [Yahoo Finance — M15.SI profile]( (sg.finance.yahoo.com)
  39. [stocks.cafe — M15 key products]( (stocks.cafe)
  40. [MT Newswires via Tiger — subscription pricing]( (itiger.com)
  41. [IMARC Group — Global textile dyes market]( (imarcgroup.com)
  42. [The Business Research Company via GII — Reactive dyes market 2026]( (cn.gii.tw)
  43. [The Business Research Company via GII — Textile dyes market 2025]( (cn.gii.tw)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.